Bifidobacterium animalis subsp. lactis HN019 and Improved Gingival Health

• Effects of oral administration of Bifidobacterium animalis subsp. lactis HN019 on the treatment of plaque-induced generalized gingivitis.

  • 2022-10-28
  • RCT · n = 30
  • Clinical oral investigations 27(1)
  • • Yara Loyanne de Almeida Silva Levi
    • Marcella Costa Ribeiro
    • Pedro Henrique Félix Silva
    • Giselle Aparecida Silva
    • Sergio Luiz de Souza Salvador
    • Sérgio Luís Scombatti de Souza
    • Renato Casarin
    • Arthur Belem Novaes Júnior
    • Mario Taba Júnior
    • Daniela Bazan Palioto
    • Heitor Marques Honório
    • Michel Reis Messora
    • Flávia Aparecida Chaves Furlaneto

  • PubMed: 36305963
  • DOI: 10.1007/s00784-022-04744-y

  6 Insights on

  • Improved Gingival Health

  • High evidence

  The test group presented a lower percentage of BoP and a higher percentage of sites with GI ≤ 1 when compared with the control group at the end of the study (p < 0.0001). At 8 weeks, the test group had a greater number of patients without generalized gingivitis than the control group (20 and 11 patients, respectively; p < 0.05).

  Effect

  Beneficial

  Effect size

  Moderate

  Significant

  Yes

  Dose

  probiotic lozenges consumed twice a day for 8 weeks